TREATMENT OF ASTHMATIC PATIENTS

The bronchial asthma can be recognized clinically by episodes of breathlessness and wheezing. While many factors have been discussed about the cause of the bronchial asthma, hypersusceptibility of the asthma apparatus may be indispensable. In this respect, following patients were observed as 64 case...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Iryo 1971/05/20, Vol.25(5), pp.339-344
Hauptverfasser: HIKITA, Yoshihira, HATTORI, Yuzuru
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 344
container_issue 5
container_start_page 339
container_title Iryo
container_volume 25
creator HIKITA, Yoshihira
HATTORI, Yuzuru
description The bronchial asthma can be recognized clinically by episodes of breathlessness and wheezing. While many factors have been discussed about the cause of the bronchial asthma, hypersusceptibility of the asthma apparatus may be indispensable. In this respect, following patients were observed as 64 cases of out-come asthmatics, 25 cases of admitted asthmatic patients and 16 cases of chronic bronchitis with asthmatic symptoms. The immunological response including reaginic and non-reaginic types may play an important role to build such hypersusceptibility. In all asthmatic cases, however, immunological response may not always be detacteble clinically either on skin testing or after inhalation challenge. Another factors may be concerned with producing the hypersusceptibility in each asthmatic patient, such as hereditary, environmental, bodily and emotional factors and so on. Treatment of the asthmatic patients must be indicated to eliminate the factors which have pro-duced the hypersusceptible asthma apparatus of each case. It may be different ways in individual asthmatics how they have acquired the hypersuscetibility. It may be necessary to analyse the factors in each case, and then physicians together with patients themselves have to strive to elimi-nate each hypersusceptibility from respective asthma apparatus for long duration. It may be thought that the treatment of asthma must be pointed not only to the bronchial asthma as disease but also to the asthma patients as human beings.
doi_str_mv 10.11261/iryo1946.25.339
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_81144535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>81144535</sourcerecordid><originalsourceid>FETCH-LOGICAL-j1710-e7f21e754f05a3adcbae2b58fb7a8f280421e9d51db479e9135ed8017a44ef0d3</originalsourceid><addsrcrecordid>eNo9kM1PwkAQxTdGgwS5ezFy8lbc2d3p7h4bBCEBMVLPm2071ZLyYRcO_Pc2Ab28Sd7vZZL3GLsHPgQQMTxXzWkHVsVDgUMp7RXrgjEqMlrYa9blXEAEsbW3rB9ClXEhUCtrsMM6CIAQ8y57TD_GSboYv6WD5WSQrNLpIklno8F7q625umM3pa8D9S-3xz4n43Q0jebL19komUdr0MAj0qUA0qhKjl76Is88iQxNmWlvSmG4arEtEIpMaUsWJFJhOGivFJW8kD32dP67b3Y_RwoHt6lCTnXtt7Q7BmcAlEKJbfDhEjxmGyrcvqk2vjm5S6OWv5z5Ohz8F_1z3xyqvCb3t5kT6PAs7XT_OP_2jaOt_AXhs2Ko</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81144535</pqid></control><display><type>article</type><title>TREATMENT OF ASTHMATIC PATIENTS</title><source>J-STAGE Free</source><source>MEDLINE</source><creator>HIKITA, Yoshihira ; HATTORI, Yuzuru</creator><creatorcontrib>HIKITA, Yoshihira ; HATTORI, Yuzuru</creatorcontrib><description>The bronchial asthma can be recognized clinically by episodes of breathlessness and wheezing. While many factors have been discussed about the cause of the bronchial asthma, hypersusceptibility of the asthma apparatus may be indispensable. In this respect, following patients were observed as 64 cases of out-come asthmatics, 25 cases of admitted asthmatic patients and 16 cases of chronic bronchitis with asthmatic symptoms. The immunological response including reaginic and non-reaginic types may play an important role to build such hypersusceptibility. In all asthmatic cases, however, immunological response may not always be detacteble clinically either on skin testing or after inhalation challenge. Another factors may be concerned with producing the hypersusceptibility in each asthmatic patient, such as hereditary, environmental, bodily and emotional factors and so on. Treatment of the asthmatic patients must be indicated to eliminate the factors which have pro-duced the hypersusceptible asthma apparatus of each case. It may be different ways in individual asthmatics how they have acquired the hypersuscetibility. It may be necessary to analyse the factors in each case, and then physicians together with patients themselves have to strive to elimi-nate each hypersusceptibility from respective asthma apparatus for long duration. It may be thought that the treatment of asthma must be pointed not only to the bronchial asthma as disease but also to the asthma patients as human beings.</description><identifier>ISSN: 0021-1699</identifier><identifier>EISSN: 1884-8729</identifier><identifier>DOI: 10.11261/iryo1946.25.339</identifier><identifier>PMID: 5115160</identifier><language>jpn</language><publisher>Japan: Japanese Society of National Medical Services</publisher><subject>Adolescent ; Adult ; Aged ; Allergens ; Antibodies - analysis ; Asthma - complications ; Asthma - genetics ; Asthma - immunology ; Asthma - therapy ; Bronchitis - complications ; Child ; Child, Preschool ; Female ; Humans ; Male ; Middle Aged ; Sex Factors ; Skin Tests</subject><ispartof>Japanese Journal of National Medical Services, 1971/05/20, Vol.25(5), pp.339-344</ispartof><rights>Japanese Society of National Medical Services</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1881,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5115160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HIKITA, Yoshihira</creatorcontrib><creatorcontrib>HATTORI, Yuzuru</creatorcontrib><title>TREATMENT OF ASTHMATIC PATIENTS</title><title>Iryo</title><addtitle>Japanese Journal of National Medical Services</addtitle><description>The bronchial asthma can be recognized clinically by episodes of breathlessness and wheezing. While many factors have been discussed about the cause of the bronchial asthma, hypersusceptibility of the asthma apparatus may be indispensable. In this respect, following patients were observed as 64 cases of out-come asthmatics, 25 cases of admitted asthmatic patients and 16 cases of chronic bronchitis with asthmatic symptoms. The immunological response including reaginic and non-reaginic types may play an important role to build such hypersusceptibility. In all asthmatic cases, however, immunological response may not always be detacteble clinically either on skin testing or after inhalation challenge. Another factors may be concerned with producing the hypersusceptibility in each asthmatic patient, such as hereditary, environmental, bodily and emotional factors and so on. Treatment of the asthmatic patients must be indicated to eliminate the factors which have pro-duced the hypersusceptible asthma apparatus of each case. It may be different ways in individual asthmatics how they have acquired the hypersuscetibility. It may be necessary to analyse the factors in each case, and then physicians together with patients themselves have to strive to elimi-nate each hypersusceptibility from respective asthma apparatus for long duration. It may be thought that the treatment of asthma must be pointed not only to the bronchial asthma as disease but also to the asthma patients as human beings.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Allergens</subject><subject>Antibodies - analysis</subject><subject>Asthma - complications</subject><subject>Asthma - genetics</subject><subject>Asthma - immunology</subject><subject>Asthma - therapy</subject><subject>Bronchitis - complications</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Sex Factors</subject><subject>Skin Tests</subject><issn>0021-1699</issn><issn>1884-8729</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1971</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1PwkAQxTdGgwS5ezFy8lbc2d3p7h4bBCEBMVLPm2071ZLyYRcO_Pc2Ab28Sd7vZZL3GLsHPgQQMTxXzWkHVsVDgUMp7RXrgjEqMlrYa9blXEAEsbW3rB9ClXEhUCtrsMM6CIAQ8y57TD_GSboYv6WD5WSQrNLpIklno8F7q625umM3pa8D9S-3xz4n43Q0jebL19komUdr0MAj0qUA0qhKjl76Is88iQxNmWlvSmG4arEtEIpMaUsWJFJhOGivFJW8kD32dP67b3Y_RwoHt6lCTnXtt7Q7BmcAlEKJbfDhEjxmGyrcvqk2vjm5S6OWv5z5Ohz8F_1z3xyqvCb3t5kT6PAs7XT_OP_2jaOt_AXhs2Ko</recordid><startdate>197105</startdate><enddate>197105</enddate><creator>HIKITA, Yoshihira</creator><creator>HATTORI, Yuzuru</creator><general>Japanese Society of National Medical Services</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>197105</creationdate><title>TREATMENT OF ASTHMATIC PATIENTS</title><author>HIKITA, Yoshihira ; HATTORI, Yuzuru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j1710-e7f21e754f05a3adcbae2b58fb7a8f280421e9d51db479e9135ed8017a44ef0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1971</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Allergens</topic><topic>Antibodies - analysis</topic><topic>Asthma - complications</topic><topic>Asthma - genetics</topic><topic>Asthma - immunology</topic><topic>Asthma - therapy</topic><topic>Bronchitis - complications</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Sex Factors</topic><topic>Skin Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HIKITA, Yoshihira</creatorcontrib><creatorcontrib>HATTORI, Yuzuru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Iryo</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HIKITA, Yoshihira</au><au>HATTORI, Yuzuru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TREATMENT OF ASTHMATIC PATIENTS</atitle><jtitle>Iryo</jtitle><addtitle>Japanese Journal of National Medical Services</addtitle><date>1971-05</date><risdate>1971</risdate><volume>25</volume><issue>5</issue><spage>339</spage><epage>344</epage><pages>339-344</pages><issn>0021-1699</issn><eissn>1884-8729</eissn><abstract>The bronchial asthma can be recognized clinically by episodes of breathlessness and wheezing. While many factors have been discussed about the cause of the bronchial asthma, hypersusceptibility of the asthma apparatus may be indispensable. In this respect, following patients were observed as 64 cases of out-come asthmatics, 25 cases of admitted asthmatic patients and 16 cases of chronic bronchitis with asthmatic symptoms. The immunological response including reaginic and non-reaginic types may play an important role to build such hypersusceptibility. In all asthmatic cases, however, immunological response may not always be detacteble clinically either on skin testing or after inhalation challenge. Another factors may be concerned with producing the hypersusceptibility in each asthmatic patient, such as hereditary, environmental, bodily and emotional factors and so on. Treatment of the asthmatic patients must be indicated to eliminate the factors which have pro-duced the hypersusceptible asthma apparatus of each case. It may be different ways in individual asthmatics how they have acquired the hypersuscetibility. It may be necessary to analyse the factors in each case, and then physicians together with patients themselves have to strive to elimi-nate each hypersusceptibility from respective asthma apparatus for long duration. It may be thought that the treatment of asthma must be pointed not only to the bronchial asthma as disease but also to the asthma patients as human beings.</abstract><cop>Japan</cop><pub>Japanese Society of National Medical Services</pub><pmid>5115160</pmid><doi>10.11261/iryo1946.25.339</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-1699
ispartof Japanese Journal of National Medical Services, 1971/05/20, Vol.25(5), pp.339-344
issn 0021-1699
1884-8729
language jpn
recordid cdi_proquest_miscellaneous_81144535
source J-STAGE Free; MEDLINE
subjects Adolescent
Adult
Aged
Allergens
Antibodies - analysis
Asthma - complications
Asthma - genetics
Asthma - immunology
Asthma - therapy
Bronchitis - complications
Child
Child, Preschool
Female
Humans
Male
Middle Aged
Sex Factors
Skin Tests
title TREATMENT OF ASTHMATIC PATIENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A48%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TREATMENT%20OF%20ASTHMATIC%20PATIENTS&rft.jtitle=Iryo&rft.au=HIKITA,%20Yoshihira&rft.date=1971-05&rft.volume=25&rft.issue=5&rft.spage=339&rft.epage=344&rft.pages=339-344&rft.issn=0021-1699&rft.eissn=1884-8729&rft_id=info:doi/10.11261/iryo1946.25.339&rft_dat=%3Cproquest_pubme%3E81144535%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=81144535&rft_id=info:pmid/5115160&rfr_iscdi=true